Cases of heparin-induced thrombocytopenia elucidate the syndrome

Chest

Volumn 127, Issue 2 SUPPL., 2005, Pages 21S-26S

  Rice, Lawrence ^a,b,c,d,e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b GLAXOSMITHKLINE   (United States)

^c Berlex   (United States)

^d Medicines Company   (United States)

^e MS 902 ^*  (United States)

Author keywords

Direct thrombin inhibitors; Drug induced thrombocytopenia; Heparin; Heparin induced thrombocytopenia; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN INHIBITOR; WARFARIN;

ADULT; AGED; ANAMNESIS; AORTA VALVE REPLACEMENT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CORONARY ARTERY BYPASS GRAFT; DRUG CONTRAINDICATION; DRUG EXPOSURE; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HEPARINIZATION; HUMAN; HYPOTENSION; LUNG EMBOLISM; MALE; MORBIDITY; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STROKE; SUPERIOR CAVA VEIN; VEIN CATHETERIZATION; VEIN THROMBOSIS;

EID: 13544252796     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.2_suppl.21S     Document Type: Article

References (18)

1. Rice L, Jackson D. Can heparin cause clotting? Heart Lung 1981; 10:331-335
2. Rhodes GR, Dixon RH, Silver D. Heparin induced thrombocytopenia: eight cases with thrombotic-hemorrhagic complications. Ann Surg 1977; 186:752-758
3. King DJ, Kelton JG. Heparin-associated thrombocytopenia. Ann Intern Med 1984; 100:535-540
4. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996; 101:502-507
5. Rice L, Huffman DM, Levine ML, et al. Heparin-induced thrombocytopenia/thrombosis syndrome: clinical manifestations and insights [abstract]. Blood 1986; 68(suppl):339a
6. Rice L, Huffman DM, Waddell CC, et al. Therapy of thromboembolic disease: the heparin thrombocytopenia/thrombosis syndrome. In: Thrombosis, anticoagulants and antiplatelet agents in clinical practice. New York, NY: Park Row, 1988; 31-36
7. Laster J, Silver D. Heparin-coated catheters and heparin-induced thrombocytopenia. J Vasc Surg 1988; 7:667-672
8. Greinacher A, Warkentin TE. Treatment of heparin-induced thrombocytopenia: an overview. In: Warkentin TE, Greinacher A, eds. Heparin-induced thrombocytopenia. 3rd ed. New York, NY: Marcel Dekker, 2004; 335-370
9. Wallis DE, Workman DL, Lewis BE, et al. Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med 1999; 106:629-635
10. Greinacher A, Volpel H, Janssens U, et al. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia. Circulation 199; 99:73-80
11. Lewis BE, Wallis DE, Berkowitz SD, et al. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 2001; 103:1838-1843
12. Warkentin TE. Clinical picture of heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A, eds. Heparin-induced thrombocytopenia. 3rd ed. New York, NY: Marcel Dekker, 2004; 53-106
13. Greinacher A, Eichler P, Lubenow N, et al. Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range. Blood 2000; 96:846-851
14. Rice L. Heparin-induced thrombocytopenia: myths and misconceptions. Arch Intern Med 2004; 164:1961-1964
15. Rice L, Attisha WK, Drexler A, Francis JL. Delayed-onset heparin-induced thrombocytopenia. Ann Intern Med 2002; 136:210-215
16. Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 2001; 135:502-506
17. Mims MP, Manian P, Rice L. Acute cardiorespiratory collapse from heparin: a consequence of heparin-induced thrombocytopenia. Eur J Haematol 2004; 72:366-369
18. Srinivasan AF, Rice L, Bartholomew JR, et al. Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia. Arch Intern Med 2004; 164:66-70